Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of selective internal radiation therapy on the (a) survival outcomes and (b) quality of life for neuroendocrine tumour patients.

No assessment has been made on the potential impact of selective internal radiation therapy (SIRT) on survival outcomes and quality of life for neuroendocrine tumour patients. However, the Department recognises the need to offer suitable treatment, including SIRT, to the patients who need it the most.

Radiotherapy treatment for cancer is highly individualised and decisions about cancer treatment are typically made by clinicians and multidisciplinary teams of healthcare professionals. They consider all aspects of a patient's health and circumstances when recommending treatment options. While certain treatments may not be advised for some patients, these decisions are based on medical assessments and what is best for the individual's overall health and well-being.